Literature DB >> 20150759

Sarcosine as a potential prostate cancer biomarker and therapeutic target.

Caitlin E Baum1, Douglas K Price, William D Figg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20150759      PMCID： PMC2874119          DOI： 10.4161/cbt.9.5.11310

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN： 1538-4047            Impact factor:   4.742


× No keyword cloud information.
  7 in total

1.  Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

Authors:  Scott A Tomlins; Daniel R Rhodes; Sven Perner; Saravana M Dhanasekaran; Rohit Mehra; Xiao-Wei Sun; Sooryanarayana Varambally; Xuhong Cao; Joelle Tchinda; Rainer Kuefer; Charles Lee; James E Montie; Rajal B Shah; Kenneth J Pienta; Mark A Rubin; Arul M Chinnaiyan
Journal:  Science       Date:  2005-10-28       Impact factor: 47.728

2.  Contrast-enhanced ultrasound imaging of prostate cancer.

Authors:  Ethan J Halpern
Journal:  Rev Urol       Date:  2006

Review 3.  New molecular biomarkers for the prognosis and management of prostate cancer--the post PSA era.

Authors:  Bridget Bickers; Claire Aukim-Hastie
Journal:  Anticancer Res       Date:  2009-08       Impact factor: 2.480

4.  The polycomb group protein EZH2 is involved in progression of prostate cancer.

Authors:  Sooryanarayana Varambally; Saravana M Dhanasekaran; Ming Zhou; Terrence R Barrette; Chandan Kumar-Sinha; Martin G Sanda; Debashis Ghosh; Kenneth J Pienta; Richard G A B Sewalt; Arie P Otte; Mark A Rubin; Arul M Chinnaiyan
Journal:  Nature       Date:  2002-10-10       Impact factor: 49.962

5.  Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression.

Authors:  Arun Sreekumar; Laila M Poisson; Thekkelnaycke M Rajendiran; Amjad P Khan; Qi Cao; Jindan Yu; Bharathi Laxman; Rohit Mehra; Robert J Lonigro; Yong Li; Mukesh K Nyati; Aarif Ahsan; Shanker Kalyana-Sundaram; Bo Han; Xuhong Cao; Jaeman Byun; Gilbert S Omenn; Debashis Ghosh; Subramaniam Pennathur; Danny C Alexander; Alvin Berger; Jeffrey R Shuster; John T Wei; Sooryanarayana Varambally; Christopher Beecher; Arul M Chinnaiyan
Journal:  Nature       Date:  2009-02-12       Impact factor: 49.962

Review 6.  Prostate cancer imaging.

Authors:  M Fuchsjäger; A Shukla-Dave; O Akin; J Barentsz; H Hricak
Journal:  Acta Radiol       Date:  2008-02       Impact factor: 1.990

Review 7.  Prostate-specific antigen and prostate cancer: prediction, detection and monitoring.

Authors:  Hans Lilja; David Ulmert; Andrew J Vickers
Journal:  Nat Rev Cancer       Date:  2008-04       Impact factor: 60.716
  7 in total
  9 in total

1.  Expression of sarcosine metabolism-related proteins according to metastatic site in breast cancer.

Authors:  Yoon Jin Cha; Do Hee Kim; Woo Hee Jung; Ja Seung Koo
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

Review 2.  Diagnostic and therapeutic biomarkers in colorectal cancer: a review.

Authors:  Jéssica Vieira de Assis; Lucélia Antunes Coutinho; Ifeoluwa Temitayo Oyeyemi; Oyetunde Timothy Oyeyemi; Rafaella Fortini E Queiroz Grenfell
Journal:  Am J Cancer Res       Date:  2022-02-15       Impact factor: 6.166

3.  SNAT2 is responsible for hyperosmotic induced sarcosine and glycine uptake in human prostate PC-3 cells.

Authors:  Carsten Uhd Nielsen; Nanna Friberg Krog; Ilham Sjekirica; Sidsel Strandgaard Nielsen; Maria L Pedersen
Journal:  Pflugers Arch       Date:  2022-09-29       Impact factor: 4.458

4.  Expression of sarcosine metabolism-related proteins in estrogen receptor negative breast cancer according to the androgen receptor and HER-2 status.

Authors:  Min Ju Kim; Woo Hee Jung; Ja Seung Koo
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01

5.  Expression of sarcosine metabolism-related proteins in invasive lobular carcinoma: comparison to invasive ductal carcinoma.

Authors:  Yoon Jin Cha; Woo Hee Jung; Nam Hoon Cho; Ja Seung Koo
Journal:  Yonsei Med J       Date:  2015-05       Impact factor: 2.759

6.  The Role of Sarcosine, Uracil, and Kynurenic Acid Metabolism in Urine for Diagnosis and Progression Monitoring of Prostate Cancer.

Authors:  Georgios Gkotsos; Christina Virgiliou; Ioanna Lagoudaki; Chrysanthi Sardeli; Nikolaos Raikos; Georgios Theodoridis; Georgios Dimitriadis
Journal:  Metabolites       Date:  2017-02-23

Review 7.  Urine markers and prostate cancer.

Authors:  Jacek Wilkosz; Magdalena Bryś; Waldemar Różański
Journal:  Cent European J Urol       Date:  2011-03-18

8.  Implications of differences in expression of sarcosine metabolism-related proteins according to the molecular subtype of breast cancer.

Authors:  Ja Kyung Yoon; Do Hee Kim; Ja Seung Koo
Journal:  J Transl Med       Date:  2014-05-28       Impact factor: 5.531

9.  Global Prioritization of Disease Candidate Metabolites Based on a Multi-omics Composite Network.

Authors:  Qianlan Yao; Yanjun Xu; Haixiu Yang; Desi Shang; Chunlong Zhang; Yunpeng Zhang; Zeguo Sun; Xinrui Shi; Li Feng; Junwei Han; Fei Su; Chunquan Li; Xia Li
Journal:  Sci Rep       Date:  2015-11-24       Impact factor: 4.379
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.